Amylin drug trial success is mixed

Published June 16, 2010

Amylin drug trial success is mixed
A new trial of Amylin Pharmaceuticals’ much-awaited diabetes drug showed it outperformed one rival but only matched the results of two others, the San Diego company said Tuesday.